Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1699273 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Enfuvirtide T/20/Ro 29,9800, HIV-1 Infusion Inhibitor

Indicates status has not been verified in more than two years